Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Crystallographic data collection and refinement statistics for WHSC1L1 1054–1285 with PTD2 and SAM.

More »

Table 1 Expand

Fig 1.

Norleucine-containing peptides can inhibit WHSC1 and WHSC1L1 activity in vitro.

Representative peptide inhibitor biochemical dose-response curves for (A) WHSC1 941–1240 and (B) WHSC1L1 1054–1285. Error bars represent the standard deviation of three independent replicates. Resulting IC50 values are reported in Table 2.

More »

Fig 1 Expand

Table 2.

Biochemical and biophysical peptide inhibitor potency values for WHSC1 941–1240 and WHSC1L1 1054–1285a.

More »

Table 2 Expand

Table 3.

Biochemical IC50 values for norleucine peptide inhibitors derived from the H4K44 and H3K36 sequencesa.

More »

Table 3 Expand

Table 4.

PTD2 biochemical IC50 values for a panel of HMT enzymes.

More »

Table 4 Expand

Fig 2.

Representative sensorgram for PTD2 binding to Avi-tagged WHSC1 941–1240 from single-cycle kinetic SPR measurements.

WHSC1 was immobilized on a streptavidin-coated chip and peptide inhibitor was co-injected with SAM utilizing a 3-fold, 5-point dilution series ending at a 20 μM top concentration. Data reported in Table 2 is presented as the standard deviation of three independent experiments.

More »

Fig 2 Expand

Fig 3.

Isothermal titration calorimetry of PTD2 binding to WHSC1 941–1240.

Upper panel, calorimetric trace for ligand titration; lower panel, binding isotherm from calorimetric trace. WHSC1 concentration in the cell was 10 μM supplemented with 100 μM SAM. PTD2 concentration in the syringe was 100 μM.

More »

Fig 3 Expand

Fig 4.

Representative SPR sensorgrams for PTD2 binding to Avi-tagged WHSC1 941–1240 in the absence or presence of SAM analogs.

WHSC1 was immobilized on a streptavidin-coated chip and peptide inhibitor was either injected in the absence of cofactor (left panel), co-injected with SAH (middle panel), or co-injected with SFG (right panel) utilizing a 2-fold, 10-point dilution series ending at a 100 μM top concentration.

More »

Fig 4 Expand

Fig 5.

WHSC1L1 1054–1285 has a similar overall structure in relation to other NSD family proteins and can form a ternary complex with SAM and PTD2.

(A) Superposition of NSD family proteins (green/yellow = WHSC1L1-PTD2 (PDB code = 6CEN); cyan = WHSC1L1 (PDB code = 5UPD); magenta = WHSC1 (PDB code = 5LSU); purple = NSD1 (PDB code = 3OOI). All protein chains are shown as ribbons; SAM and PTD2 are depicted in stick representation. (B) Structure of WHSC1L1-PTD2-SAM ternary complex. Hydrogen bonds are indicated with dashed lines. (C) Superposition of WHSC1L1-PTD2 and SETD2-H3.3 K36M (grey; PDB code = 5JJY).

More »

Fig 5 Expand